Completed TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) NCT00563784 Conditions Adenocarcinoma, Adenocarcinoma, Clear Cell, Bronchial Neoplasms, +17 more Locations University of Texas MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 Conditions Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States View all 1007 locations View more locations Show fewer locations Loading locations... View Trial Details
